knowledge -WSS

knowledge

author：explore 2025-09-29 18:16:50 - browse：942

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Study suggests Covid rebound is far more common with Paxlovid than without

WSS

Experimental asthma app from Apple and Anthem shows promise

How to save health care price transparency rules

Pushing for an NIH office for post

Medical school prerequisites are outdated

FDA advisers back CAR

Ventyx halts psoriasis drug development after lackluster trial results

Wikipedia

knowledge

focus

Peter Hotez and the public health issue of online harassment

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Apple is now the first public company to be valued at $3 trillion

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Anesthesiologist group: stop taking Ozempic before surgery

FDA advisers back CAR

Heart attack and stroke risk calculators need revising

Steward Health Care Massachusetts hospitals face fiscal disaster

Trump demands the U.S. pay no more for drugs than other countries … again

EPA limits use of carcinogenic gas for sterilizing medical devices

hotspot

Ohio still needs to do more to protect the right to abortion

Steward Health Care Massachusetts hospitals face fiscal disaster

Ventyx halts psoriasis drug development after lackluster trial results

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Cancer diagnosis changes perspective doctor, former hospital CEO

A letter from the executive editor: STAT UnitedHealth investigation

entertainment

hotspot

hotspot

explore